Gynesonics

Advancing technology. Improving women's lives.

SonataSys-Logo_RGB

Transcervical Fibroid Ablation for Treatment of Symptomatic Uterine Fibroids

The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure to treat symptomatic uterine fibroids.

  • Delivers a breakthrough alternative to hysterectomy and myomectomy
  • Transcervical delivery avoids the peritoneal cavity and does not require general anesthesia
  • Treats most fibroid types including submucous, intramural, transmural, and subserous

SONATA Pivotal IDE Trial Results Through 3 Years1,2

Sonata-InfographicBrochure-50%-OL-020421-01
Sonata-InfographicBrochure-RND15-95%
Sonata-InfographicBrochure-HMB-92%
Sonata-InfographicBrochure-Treatsatisfaction94%-OL
VISIT OUR PUBLICATIONS

1. Chudnoff S, Guido R, Roy K, Levine D, Mihalov L, Garza-Leal JG. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019; 133:13-22.

2. Lukes A, Green MA. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata. J Gynecol Surg. 2020;36:5, 228-233.

Visit the Sonata Treatment Website

For more information about the Sonata System for patients and healthcare providers:

VISIT OUR PRODUCT SITE

Indications and Safety Information

The Sonata System is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding.

FULL SAFETY INFORMATION